DisperseBio

DisperseBio
DisperseBio develops peptide-based solutions to prevent biofilm formation, offering an eco-friendly alternative to toxic anti-fouling chemicals.
About
What does DisperseBio do?
DisperseBio engineers protein-based solutions to combat biofilm and biofouling, a costly challenge across various industries. Their technology utilizes synthetic peptides that activate natural microbial dispersion pathways, preventing biofilm formation without using toxic chemicals. This approach offers a sustainable, cost-effective, and environmentally friendly alternative for sectors including marine coatings, desalination, water treatment, and healthcare.
Where is DisperseBio headquartered?
DisperseBio is headquartered in Tel Aviv, Israel.
When was DisperseBio founded?
DisperseBio was founded in 2021.
What industry does DisperseBio operate in?
DisperseBio operates in Life Sciences, Biotech, Drug Discovery, Therapeutics, MedTech, Climate Tech.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.
AI-powered platform accelerating biological research and drug discovery.
A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.
Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.
An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.